Agilent AdvanceBio SEC Columns for Aggregate Analysis: Instrument Compatibility

Importance of Topic

Size exclusion chromatography (SEC) is critical for ensuring the quality and safety of biotherapeutic proteins by quantifying monomeric forms and detecting aggregates. Reliable aggregate analysis supports regulatory compliance and guides process development in research and manufacturing.

Study Objectives and Overview

This technical overview introduces Agilent AdvanceBio SEC columns and demonstrates their compatibility across a range of liquid chromatography systems. Key goals include assessing column efficiency, stability under high-strength phosphate buffers, and cross-platform reproducibility for monoclonal antibody aggregate analysis.

Methodology

AdvanceBio SEC columns are packed with 2.7 µm polymer-coated silica particles to minimize nonspecific binding and improve peak shape. Two pore sizes are available: 300 Å optimized for antibody aggregates and 130 Å for smaller proteins and peptides. Columns range from 7.8 mm × 300 mm and 4.6 mm × 300 mm for high resolution to 4.6 mm × 150 mm for rapid throughput. Typical mobile phase is 150 mM sodium phosphate buffer, pH 7.0, at flow rates of 1.0 mL/min for 7.8 mm and 0.35 mL/min for 4.6 mm columns. Analyses use isocratic elution and UV detection at 220 nm.

Instrumentation Used

• Agilent 1100 HPLC (legacy, 400 bar)
• Agilent 1260 Infinity Quaternary Bio-Inert LC (600 bar)
• Agilent 1290 Infinity Binary LC with G1315D DAD and bio-inert flow cell (1,200 bar)
• Waters H-Class and Waters Alliance systems for method transfer studies

Main Results and Discussion

• Chromatograms from 1100, 1260 and 1290 systems show nearly identical retention and resolution of monomer and dimer species, confirming broad instrument compatibility.
• Comparison of 7.8 mm and 4.6 mm columns demonstrates consistent separation performance when flow rate and injection volume are scaled.
• Lifetime testing over 1,200 injections in phosphate buffer shows minimal change in monomer and aggregate peak areas, highlighting column robustness.
• Temperature variation studies reveal modest effects on resolution and aggregation levels, underscoring the value of controlled column and sample environments.
• Cross-vendor comparisons on Waters systems identify retention time shifts attributable to flow accuracy and extra-column volume, emphasizing best practices for method transfer.

Benefits and Practical Applications

• Low nonspecific binding enhances recovery and peak symmetry for mAbs and ADCs.
• Column stability under aggressive buffers reduces downtime and maintenance.
• Wide range of dimensions meets both high-throughput screening and high-resolution needs.
• Compatibility with legacy HPLC and UHPLC systems simplifies laboratory upgrades.

Future Trends and Possibilities

• Integration of multi-detector configurations (light scattering, refractive index) for absolute molecular weight determination.
• Automation and online sampling to support high-throughput biologics screening.
• Development of stationary phases tailored to emerging biotherapeutic formats such as bispecific antibodies and antibody fragments.
• Enhanced temperature-controlled modules for improved method robustness under variable laboratory environments.

Conclusion

Agilent AdvanceBio SEC columns deliver consistent, high-efficiency aggregate analysis across diverse chromatography platforms. Their robust polymer-coated stationary phase, broad instrument compatibility, and scalable dimensions make them a versatile tool for biotherapeutic quality control and research applications.